{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T05:12:54Z","timestamp":1736917974157,"version":"3.33.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,13]]},"DOI":"10.7759\/cureus.77406","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T07:26:40Z","timestamp":1736839600000},"source":"Crossref","is-referenced-by-count":0,"title":["Remimazolam for Sedation and Trachospray for Topicalization During Flexible Nasal Intubation in a Spontaneously Breathing Patient"],"prefix":"10.7759","author":[{"given":"Loes","family":"Bruijstens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Koch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond","family":"Van Der Wal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas","family":"Van Eijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rgen","family":"Bruhn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/anae.14904","article-title":"Difficult Airway Society guidelines for awake tracheal intubation (ATI) in adults","volume":"75","author":"Ahmad I","year":"2020","unstructured":"Ahmad I, El-Boghdadly K, Bhagrath R, et al.. Difficult Airway Society guidelines for awake tracheal intubation (ATI) in adults. Anaesthesia. 2020, 75:509-28. 10.1111\/anae.14904","journal-title":"Anaesthesia"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01299-8","article-title":"Remimazolam: first approval","volume":"80","author":"Keam SJ","year":"2020","unstructured":"Keam SJ. Remimazolam: first approval. Drugs. 2020, 80:625-33. 10.1007\/s40265-020-01299-8","journal-title":"Drugs"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000003103","article-title":"Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers: part I. pharmacokinetics and clinical pharmacodynamics","volume":"132","author":"Sch\u00fcttler J","year":"2020","unstructured":"Sch\u00fcttler J, Eisenried A, Lerch M, Fechner J, Jeleazcov C, Ihmsen H. Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers: part I. pharmacokinetics and clinical pharmacodynamics. Anesthesiology. 2020, 132:636-51. 10.1097\/ALN.0000000000003103","journal-title":"Anesthesiology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2147\/MDER.S292529","article-title":"Comparative in-vitro study of the Trachospray, a new device for topical anaesthesia of the upper airway","volume":"14","author":"van Geffen GJ","year":"2021","unstructured":"van Geffen GJ, Markerink H, van Barneveld M, Verhoeven F, Scheffer GJ, Bruhn J. Comparative in-vitro study of the Trachospray, a new device for topical anaesthesia of the upper airway. Med Devices (Auckl). 2021, 14:9-14. 10.2147\/MDER.S292529","journal-title":"Med Devices (Auckl)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/anae.15348","article-title":"Clinical evaluation of the Trachospray device for upper airway anaesthesia","volume":"76","author":"van Geffen GJ","year":"2021","unstructured":"van Geffen GJ, Markerink H, van Barneveld M, Scheffer GJ, Bruhn J. Clinical evaluation of the Trachospray device for upper airway anaesthesia. Anaesthesia. 2021, 76:569-70. 10.1111\/anae.15348","journal-title":"Anaesthesia"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s12630-021-02008-z","article-title":"Canadian airway focus group updated consensus-based recommendations for management of the difficult airway: part 2. planning and implementing safe management of the patient with an anticipated difficult airway","volume":"68","author":"Law JA","year":"2021","unstructured":"Law JA, Duggan LV, Asselin M, et al.. Canadian airway focus group updated consensus-based recommendations for management of the difficult airway: part 2. planning and implementing safe management of the patient with an anticipated difficult airway. Can J Anaesth. 2021, 68:1405-36. 10.1007\/s12630-021-02008-z","journal-title":"Can J Anaesth"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/aas.12914","article-title":"Claims for compensation after injuries related to airway management: a nationwide study covering 15 years","volume":"61","author":"Fornebo I","year":"2017","unstructured":"Fornebo I, Simonsen KA, Bukholm IR, Kongsgaard UE. Claims for compensation after injuries related to airway management: a nationwide study covering 15 years. Acta Anaesthesiol Scand. 2017, 61:781-9. 10.1111\/aas.12914","journal-title":"Acta Anaesthesiol Scand"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-019-02800-3","article-title":"Safety, pharmacokinetic and pharmacodynamic properties of single ascending dose and continuous infusion of remimazolam besylate in healthy Chinese volunteers","volume":"76","author":"Sheng XY","year":"2020","unstructured":"Sheng XY, Liang Y, Yang XY, Li LE, Ye X, Zhao X, Cui YM. Safety, pharmacokinetic and pharmacodynamic properties of single ascending dose and continuous infusion of remimazolam besylate in healthy Chinese volunteers. Eur J Clin Pharmacol. 2020, 76:383-91. 10.1007\/s00228-019-02800-3","journal-title":"Eur J Clin Pharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00540-020-02788-6","article-title":"Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb\/III trial","volume":"34","author":"Doi M","year":"2020","unstructured":"Doi M, Morita K, Takeda J, Sakamoto A, Yamakage M, Suzuki T. Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb\/III trial. J Anesth. 2020, 34:543-53. 10.1007\/s00540-020-02788-6","journal-title":"J Anesth"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinane.2020.109899","article-title":"Population pharmacokinetic\/pharmacodynamic modeling for remimazolam in the induction and maintenance of general anesthesia in healthy subjects and in surgical subjects","volume":"66","author":"Zhou J","year":"2020","unstructured":"Zhou J, Leonowens C, Ivaturi VD, et al.. Population pharmacokinetic\/pharmacodynamic modeling for remimazolam in the induction and maintenance of general anesthesia in healthy subjects and in surgical subjects. J Clin Anesth. 2020, 66:109899. 10.1016\/j.jclinane.2020.109899","journal-title":"J Clin Anesth"},{"key":"ref11","article-title":"Remimazolam as the sole sedative for fiberoptic intubation of an apprehensive patient with a difficult airway","volume":"5","author":"Bekker A","year":"2022","unstructured":"Bekker A, Asad S. Remimazolam as the sole sedative for fiberoptic intubation of an apprehensive patient with a difficult airway. Anesthesiol Case Rep. 2022, 5:1-3.","journal-title":"Anesthesiol Case Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/anr3.12298","article-title":"Remimazolam sedation for awake tracheal intubation","volume":"12","author":"Kolb B","year":"2024","unstructured":"Kolb B, Lewis T, Large J, Wilson M, Ode K. Remimazolam sedation for awake tracheal intubation. Anaesth Rep. 2024, 12:e12298. 10.1002\/anr3.12298","journal-title":"Anaesth Rep"},{"key":"ref13","unstructured":"Byfavo | European Medicines Agency (EMA). (2024). Accessed. December 11, 2024: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/byfavo."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/EJA.0000000000001902","article-title":"Remimazolam and serious adverse events: a scoping review","volume":"40","author":"Kempenaers S","year":"2023","unstructured":"Kempenaers S, Hansen TG, Van de Velde M. Remimazolam and serious adverse events: a scoping review. Eur J Anaesthesiol. 2023, 40:841-53. 10.1097\/EJA.0000000000001902","journal-title":"Eur J Anaesthesiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/306338-remimazolam-for-sedation-and-trachospray-for-topicalization-during-flexible-nasal-intubation-in-a-spontaneously-breathing-patient","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T07:26:43Z","timestamp":1736839603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/306338-remimazolam-for-sedation-and-trachospray-for-topicalization-during-flexible-nasal-intubation-in-a-spontaneously-breathing-patient"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,13]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.77406","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,13]]}}}